Preparation and pharmacokinetics of curcumin nanostructured lipid carriers in rats

Journal of China Pharmaceutical University

Volumn 43, Issue 5, 2012, Pages 412-417

  Chen, Xi ^a   Xiao, Yan Yu ^a   Chen, Yi Nan ^a   Ping, Qi Neng ^a   Zhang, Can ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Curcumin; Nanostructured lipid carriers; Oral bioavailabilities; Pharmacokinetics; Physicochemical properties

Indexed keywords

CURCUMIN;

ARTICLE; DIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MORPHOLOGY; NONHUMAN; PARTICLE SIZE; ZETA POTENTIAL;

EID: 84879063595     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Maiti K, Mukherjee K, Gantait A, et al. Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats[J]. Int J Pharm,2007,330(1/2):155-163. (Pubitemid 46097368)
2. Cui J, Yu B, Zhao Y, et al. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems[J]. Int J Pharm,2009,371(1/2):148- 155.
3. Shaikh J, Ankola DD, Beniwal V, et al. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer[J]. Eur J Pharm Sci,2009,37(3/4):223-230.
4. Han G, Zhai L, Zhao LL, et al. Pharmacokinetics of curcumin solid disperision in rats in vivo[J]. Chin Pharm J,2009,44(9):698-700.
5. Han G, Xu JH, Li WN, et al. Study on preparation of the inclusion compound of curcumin with β-cyclodextrin[J]. Chin Tradit Patent Med,2004,27(12):946-948.
6. Ma Z, Shayeganpour A, Brocks DR, et al. High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin[J]. Biomed Chromatogr,2007,21(5):546-552. (Pubitemid 46736190)
7. Jenning V, Thunemann AF, Gohla SH, et al. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids[J]. Int J Pharm,2000,199(2):167-177. (Pubitemid 30236188)
8. Mehnert W, Mader K. Solid lipid nanoparticles: production, characterization and applications[J]. Adv Drug Deliv Rev,2001,47(2/3):165-196. (Pubitemid 32324113)
9. Lin X, Li X, Zheng L, et al. Preparation and characterization of monocaprate nanostructured lipid carriers[J]. Collodis Surf A Physicochem Eng Asp,2007,311(1/2/3):106-111.
10. Souto EB, Wissing SA, Barbosa CM, et al. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery[J]. Int J Pharm,2004,278(1):71-77. (Pubitemid 38670438)
11. Chen Y, Li G, Wu X, et al. Self-microemulsifying drug delivery system (SMEDDS) of vinpocetine: formulation development and in vivo assessment[J]. Biol Pharm Bull,2008,31(1):118-125.
12. 3H] curcumin[J]. Toxicology,1981,22(4):337-344.
13. Ravindranath V, Chandrasekhara N. In vitro studies on the intestinal absorption of curcumin in rats[J]. Toxicology,1981,20(2/3):251-257. (Pubitemid 11117911)
14. Asai A, Miyazawa T. Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma[J]. Life Sci,2000,67(23):2785-2793.
15. Lei BK, Zhang C, Jin F. Preparation and in vivo biotransformation of curcumin in micelles[J]. Chin Pham J,2010,45(21):1639-1643. of Novel Drugs